Literature DB >> 2334643

Non-invasive quantitation of liver iron-overload by magnetic resonance imaging.

J P Kaltwasser1, R Gottschalk, K P Schalk, W Hartl.   

Abstract

A standard magnetic resonance imaging (MRI) system allowing spin echo times of 10 ms was used to quantitate liver iron concentration in nine healthy normal subjects and 13 patients with various grades of iron overload. Body iron status was estimated by measuring the serum ferritin concentration. In 11 subjects (two normal healthy controls, eight patients with HLA-related hereditary haemochromatosis and one patient with thalassaemia major) non-haem hepatic iron concentration was determined chemically in biopsy specimens (dry weight), in parallel to serum ferritin and MRI-T2 relaxation times. A moderate correlation (r = 0.79) was obtained for the correlation of the T2-relaxation rate (1/T2) and serum ferritin of the 22 subjects investigated. A much closer correlation (r = 0.98) was observed for the 1/T2 liver iron relationship in the 10 subjects analysed by liver biopsy. It is concluded from these preliminary observations, that MR-imaging may provide a useful non-invasive tool for the quantitative determination of liver iron in iron overload-syndromes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334643     DOI: 10.1111/j.1365-2141.1990.tb02596.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

1.  Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload.

Authors:  P D Jensen; F T Jensen; T Christensen; L Heickendorff; L G Jensen; J Ellegaard
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

2.  Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin.

Authors:  Bryan D Maliken; William F Avrin; James E Nelson; Jody Mooney; Sankaran Kumar; Kris V Kowdley
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

3.  Follow-up study of thyroid function in polytransfused thalassemic patients.

Authors:  M Maggiolini; G De Luca; M Bria; D Sisci; S Aquila; V Pezzi; M Lanzino; A Giorno; O Tamburrini; M Della Sala; E Corcioni; C Brancati; S Ando
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

4.  Comparison of whole liver and small region-of-interest measurements of MRI liver R2* in children with iron overload.

Authors:  M Beth McCarville; Claudia M Hillenbrand; Ralf B Loeffler; Matthew P Smeltzer; Ruitan Song; Chin-Shang Li; Jane S Hankins
Journal:  Pediatr Radiol       Date:  2010-03-24

5.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

Authors:  John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

Review 6.  Liver iron content determination by magnetic resonance imaging.

Authors:  Konstantinos Tziomalos; Vassilios Perifanis
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 7.  Cardiovascular magnetic resonance T2* for tissue iron assessment in the heart.

Authors:  Taigang He
Journal:  Quant Imaging Med Surg       Date:  2014-10

Review 8.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

Review 9.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

10.  The role of MR imaging in detection of hepatic iron overload in patients with cirrhosis of different origins.

Authors:  Edyta Szurowska; Katarzyna Sikorska; E Izycka-Swieszewska; Tomasz Nowicki; Tomasz Romanowski; Krzysztof P Bielawski; Michał Studniarek
Journal:  BMC Gastroenterol       Date:  2010-01-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.